To test this hypothesis, we first transfected a mutated SALL1 (mSALL1) encoding a protein in which the conserved 12-amino acid peptide motif that specifically binds to NuRD was deleted, into breast cancer cells and determined the capacity for senescence induction (Additional file 1: Figure S5). This evidence concerns the gene SALL1 and breast carcinoma.